Correction to: Nature Structural & Molecular Biology https://doi.org/10.1038/s41594-025-01531-7, published online 19 May 2025. In the version of this article initially published, the competing interests section stated that the authors declare no competing interests and has now been amended to “Oregon Health and Science University, M.K.R., J.S.D. and A.N. have a financial interest in the ELQ compounds which were used in this research, and which have been licensed for commercial development.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Michael K. Riscoe
Potent acridone antimalarial against all three life stages of Plasmodium
|
By Papireddy Kancharla, Rozalia A. Dodean, Yuexin Li, Xiaowei Zhang, SEAN KELLY, Jordan Charlton, Jinghua Lu, Diana Caridha, Xiannu Jin, William Dennis, Karl Kudyba, Cameron Blount, Jesse P. DeLuca, Chau Vuong, Hieu Dinh, Monica Martin, Brandon Pybus, Anongruk Chim-Ong, Liwang Cui, Tarrick Qahash, Douglas A Shoue, Michael T. Ferdig, Frank P. Mockenhaupt, Welmoed van Loon, Heather M. Kudyba, Joel Vega-Rodríguez, Martin Okitwi, Carol Green, Ying Liu, Sarah Farrell, Alexandra S. Probst, Aaron Nilsen, J. Stone Doggett, Geoffrey I. McFadden, Christopher D. Goodman, Flaminia Catteruccia, Philip Rosenthal, Michael K. Riscoe, Alison Roth, Jane Kelly, Angely J. Binauhan, Kimberly Navarrete, Laurize Garcia, Jianbing Mu, Michael S. Madejczyk, Sharon McEnearney, Kristina Pannone, Kennedy Mdaki, Susan Leed, Geoffrey C. Chin, Jules M. Ndoli, Oriana Kreutzfeld, Cristina Docan, Aaron Agulay, Jon Mirsalis, P. Holland Alday, Roland A. Cooper
|
Nature
Verified
Abstract Antimalarial therapeutics ideally should target all three major Plasmodium life cycle stages. Here we present an acridone antimalarial chemotype that is potent against blood, liver, and mosquito stages of malaria parasites.
In vivo screen of Plasmodium targets for mosquito-based malaria control - Nature
Abstract The decline in malaria deaths has recently stalled owing to several factors, including the widespread resistance of Anopheles vectors to the insecticides used in long-lasting insecticide-treated nets (LLINs)1,2. One way to mitigate insecticide resistance is to directly kill parasites during their mosquito-stage of development by incorporating antiparasitic compounds into LLINs. This strategy can prevent onward parasite transmission even when insecticides lose efficacy3,4.
The Combination of Buparvaquone and ELQ316 Exhibit a Stronger Effect than ELQ316 and Imidocarb Against Babesia bovis In Vitro
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
The Combination of Buparvaquone and ELQ316 Exhibits a Stronger Synergistic Effect Compared to the Combination of ELQ316 with Imidocarb, on the Survival of Babesia bovis in In Vitro Cultures
Preprint Article Version 1 This version is not peer-reviewed Version 1 : Received: 27 September 2024 / Approved: 29 September 2024 / Online: 30 September 2024 (12:26:27 CEST) Cardillo, N. M.; Villarino, N. F.; Lacy, P. A.; Riscoe, M. K.; Doggett, J. S.; Ueti, M. W.; Chung, C. J.; Suarez, C. E. The Combination of Buparvaquone and ELQ316 Exhibits a Stronger Synergistic Effect Compared to the Combination of ELQ316 with Imidocarb, on the Survival of Babesia bovis in In Vitro Cultures.
Novel Endochin-Like Quinolones Exhibit Potent In Vitro Activity against Plasmodium knowlesi but Do Not Synergize with Proguanil
Susceptibility Donelly A. van Schalkwyk, Michael K. Riscoe, Sovitj Pou, Rolf W. Winter, Aaron Nilsen, Maëlle Duffey, Robert W. Moon, Colin J. Sutherland DOI: 10.1128/AAC.02549-19 ABSTRACT Quinolones, such as the antimalarial atovaquone, are inhibitors of the malarial mitochondrial cytochrome bc1 complex, a target critical to the survival of both liver- and blood-stage parasites, making these drugs useful as both prophylaxis and treatment.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Michael K.
Contact Michael K., search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack